| Total | Prevalence (%) | ||
---|---|---|---|---|
Men | Women | P | ||
C-OPLL | 4.10 [3.23–4.97] | 4.12 [3.05–5.19] | 4.06 [2.56–5.56] | 0.949 |
T-OPLL | 2.25 [1.60–2.90] | 1.57 [0.90–2.24] | 3.61 [2.19–5.03] | 0.004 |
L-OPLL | 0.80 [0.41–1.19] | 0.75 [0.29–1.21] | 0.90 [0.18–1.62] | 0.717 |
C-OLF | 0.25 [0.03–0.47] | 0.22 [0–0.48] | 0.30 [0–0.72] | 1.000 |
T-OLF | 37.65 [35.52–39.78] | 36.10 [33.53–38.68] | 40.75 [37.01–44.50] | 0.043 |
L-OLF | 1.45 [0.93–1.97] | 1.04 [0.50–1.60] | 2.26 [1.12–3.39] | 0.033 |
C-OALL | 6.60 [5.51–7.69] | 7.86 [6.42–9.31] | 4.06 [2.56–5.56] | 0.001 |
T-OALL | 19.15 [17.42–20.88] | 22.17 [19.94–24.40] | 13.08 [10.51–15.65] | < 0.001 |
L-OALL | 1.95 [1.34–2.56] | 2.47 [1.64–3.31] | 0.90 [0.18–1.62] | 0.017 |
ONL | 31.50 [29.46–33.54] | 38.58 [35.96–41.19] | 17.29 [14.41–20.18] | < 0.001 |
DISH | 3.85 [3.01–4.69] | 4.87 [3.71–6.02] | 1.80 [0.79–2.82] | 0.001 |